Publicaciones en colaboración con investigadores/as de Institute Curie (11)

2024

  1. Atezolizumab Combined with Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer with a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial

    Journal of Clinical Oncology

2023

  1. EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy

    European Journal of Cancer, Vol. 181, pp. 79-91

  2. European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission

    The Lancet Oncology, Vol. 24, Núm. 1, pp. e11-e56

2022

  1. SUCCOR cone study: conization before radical hysterectomy

    International Journal of Gynecological Cancer, Vol. 32, Núm. 2, pp. 117-124

  2. The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: Unresolved Issues to be Addressed for the Next Ninth Edition of the TNM Classification of Malignant Tumors

    Journal of Thoracic Oncology, Vol. 17, Núm. 6, pp. 838-851

2021

  1. Radical hysterectomy in early cervical cancer in Europe: Characteristics, outcomes and evaluation of ESGO quality indicators

    International Journal of Gynecological Cancer, Vol. 31, Núm. 9, pp. 1212-1219

2020

  1. SUCCOR study: An international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer

    International Journal of Gynecological Cancer

2016

  1. The Heterogeneity of Ly6Chi Monocytes Controls Their Differentiation into iNOS+ Macrophages or Monocyte-Derived Dendritic Cells

    Immunity, Vol. 45, Núm. 6, pp. 1205-1218

2014

  1. Awareness and understanding of cancer immunotherapy in Europe

    Human Vaccines and Immunotherapeutics, Vol. 10, Núm. 7, pp. 1828-1835

2011

  1. Identifying polyglutamine protein species in situ that best predict neurodegeneration

    Nature Chemical Biology, Vol. 7, Núm. 12, pp. 925-934

2003

  1. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow

    Blood, Vol. 102, Núm. 8, pp. 3043-3051